Stefanie Votteler

Title: Stefanie Votteler: Innovator in Blood Treatment Technologies

Introduction

Stefanie Votteler is a prominent inventor based in Reutlingen, Germany. She has made significant contributions to the field of medical technology, particularly in blood treatment devices. With a total of two patents to her name, her work focuses on innovative solutions for critical health issues.

Latest Patents

One of her latest patents is a blood treatment device comprising alkaline phosphatase. This invention is designed to dephosphorylate extracellular adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), and/or lipopolysaccharide (LPS) in the blood of patients. The device is intended for use in an extracorporeal blood circuit and includes a matrix with alkaline phosphatase immobilized on it. This technology aims to treat infections, particularly blood or systemic infections like sepsis, and to address sepsis-associated acute kidney injury (AKI).

Another notable patent is for a device and method for the delivery of a thrombin-activated fibrin sealant. This invention features a dispenser designed for hemostasis, which includes a container for a fibrinogen solution and an activation compartment. The activation compartment contains a functionalized support with immobilized thrombin, allowing for the generation and dispensing of polymerizing fibrin as a sealant upon dispensing the fibrinogen solution.

Career Highlights

Stefanie Votteler is currently associated with Gambro Lundia AB, where she continues to develop innovative medical technologies. Her work has been instrumental in advancing treatment options for patients in critical care settings.

Collaborations

Stefanie has collaborated with notable colleagues such as Jan Swartjes and Markus Storr, contributing to the development of her groundbreaking inventions.

Conclusion

Stefanie Votteler's contributions to blood treatment technologies highlight her role as an influential inventor in the medical field. Her innovative patents reflect her commitment to improving patient care and addressing critical health challenges.